NDUFA13 Gene Hurthle Cell Thyroid Carcinoma Due to Germline NDUFA13 Mutation Genetic Test sale cost 4400 AED
MUTYH Gene Familial Adenomatous Polyposis Type 2 Genetic Test sale cost 4400 AED MUTYH Gene Familial Adenomatous Polyposis Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility to Genetic Test sale cost 4400 AED XRCC3 Gene Melanoma Cutaneous Malignant Familial Type 6 Susceptibility to Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NDUFA13 Gene Hurthle Cell Thyroid Carcinoma Due to Germline NDUFA13 Mutation Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NDUFA13 gene, also known as GRIM-19, plays a critical role in the proper functioning of the mitochondrial respiratory chain, which is essential for cellular energy production. Mutations in this gene have been linked to various medical conditions, including Hurthle cell thyroid carcinoma (HCTC), a rare and aggressive form of thyroid cancer characterized by the presence of large, eosinophilic cells known as Hurthle cells.

Given the genetic basis of HCTC associated with NDUFA13 mutations, genetic testing can be a valuable tool for early detection, diagnosis, and management of this condition. DNA Labs UAE offers a specialized genetic test designed to identify germline mutations in the NDUFA13 gene, which can predispose individuals to Hurthle cell thyroid carcinoma. This test is crucial for individuals with a family history of thyroid cancer or those who exhibit symptoms associated with HCTC, as it can provide vital information for personalized treatment planning and preventive strategies.

The cost of the NDUFA13 gene genetic test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists and clinicians, the test involves a simple blood draw or cheek swab. Results from this test not only aid in the diagnosis of HCTC but also help in assessing the risk for family members, guiding surgical and therapeutic decisions, and improving overall patient outcomes through personalized medicine approaches.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NDUFA13 Gene Hurthle Cell Thyroid Carcinoma Genetic Test

Welcome to DNA Labs UAE, where we provide comprehensive genetic testing services. In this blog post, we will discuss the NDUFA13 gene, germline NDUFA13 mutation, and the NGS genetic test for Hurthle cell thyroid carcinoma.

Test Name: NDUFA13 Gene Hurthle Cell Thyroid Carcinoma due to Germline NDUFA13 Mutation Genetic Test

  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

If you are considering the NDUFA13 Gene Hurthle Cell Thyroid Carcinoma Genetic Test, it is important to provide your clinical history to the oncologist. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by NDUFA13 Gene Hurthle Cell Thyroid Carcinoma due to germline NDUFA13 mutation.

Test Details

The NDUFA13 gene is responsible for producing a protein called NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13. This protein is part of the mitochondrial complex I, which plays a role in the electron transport chain and energy production within cells.

Hurthle cell thyroid carcinoma is a type of thyroid cancer that originates from the follicular cells of the thyroid gland. It is characterized by the presence of Hurthle cells, which are large cells with abundant eosinophilic cytoplasm.

A germline NDUFA13 mutation refers to a genetic mutation in the NDUFA13 gene that is present in the germline cells. These cells give rise to eggs or sperm, meaning the mutation can be inherited from one or both parents and passed on to future generations.

NGS (Next-Generation Sequencing) Genetic Test is a technique used to analyze multiple genes simultaneously and identify genetic mutations or variations associated with diseases or conditions. In the context of NDUFA13 gene and Hurthle cell thyroid carcinoma, an NGS genetic test can identify mutations in the NDUFA13 gene associated with this specific type of thyroid cancer.

By identifying a germline NDUFA13 mutation through NGS genetic testing, individuals at risk for Hurthle cell thyroid carcinoma can be identified early on. This allows for more effective screening, surveillance, and management strategies to reduce the risk or detect the cancer at an earlier stage. Additionally, it aids in genetic counseling for affected individuals and their families.

Conclusion

The NDUFA13 Gene Hurthle Cell Thyroid Carcinoma Genetic Test offered by DNA Labs UAE provides valuable insights into the risk of developing Hurthle cell thyroid carcinoma. Early identification of germline NDUFA13 mutations allows for proactive measures to manage and reduce the risk of this specific type of thyroid cancer. Consult with our oncologist and genetic counselors to understand the implications of NDUFA13 gene mutations and take control of your health.

Test Name NDUFA13 Gene Hurthle cell thyroid carcinoma due to germline NDUFA13 mutation Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NDUFA13 Gene Hurthle cell thyroid carcinoma, due to germline NDUFA13 mutation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NDUFA13 Gene Hurthle cell thyroid carcinoma, due to germline NDUFA13 mutation NGS Genetic DNA Test gene NDUFA13
Test Details

The NDUFA13 gene is responsible for providing instructions to produce a protein called NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13. This protein is a part of the mitochondrial complex I, which is involved in the electron transport chain and energy production within cells.

Hurthle cell thyroid carcinoma is a type of thyroid cancer that originates from the follicular cells of the thyroid gland. It is characterized by the presence of Hurthle cells, which are large cells with abundant eosinophilic cytoplasm.

A germline NDUFA13 mutation refers to a genetic mutation in the NDUFA13 gene that is present in the germline cells, which are the cells that give rise to eggs or sperm. This means that the mutation can be inherited from one or both parents and can be passed on to future generations.

NGS (Next-Generation Sequencing) Genetic Test is a technique used to analyze multiple genes simultaneously and identify genetic mutations or variations that may be associated with certain diseases or conditions. In the context of NDUFA13 gene and Hurthle cell thyroid carcinoma, an NGS genetic test can be used to identify mutations in the NDUFA13 gene that may be associated with the development of this specific type of thyroid cancer.

By identifying a germline NDUFA13 mutation through NGS genetic testing, individuals at risk for Hurthle cell thyroid carcinoma can be identified early on. This can lead to more effective screening, surveillance, and management strategies to reduce the risk or detect the cancer at an earlier stage. Additionally, it can help in genetic counseling for affected individuals and their families.

SKU: TEST-4496 Category:

Related products